Who
Robert J. DelAversano
Principal Financial Officer
Company insider
Files Form 4 as: Principal Financial Officer, Grace Therapeutics; VP, Finance, Oncosec Medical; Officer, U.S. Gold.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $4,648
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 10 Apr 2018
- Last trade
- 28 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 1 Sep 2026 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,660 at $0.00 | filing |
| 28 Aug 2026filed 1 Sep 2026 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,660 at $0.00 | filing |
| 14 Apr 2025filed 16 Apr 2025 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,130 at $0.00 | filing |
| 6 May 2024filed 8 May 2024 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,500 at $0.00 | filing |
| 9 Feb 2023filed 9 Feb 2023 | Oncosec Medical | SEC FORM 4 Sold | $5540 at $1.37 | filing |
| 4 Nov 2022filed 4 Nov 2022 | Oncosec Medical | SEC FORM 4 Sold | $105283 at $0.37 | filing |
| 5 Aug 2022filed 5 Aug 2022 | Oncosec Medical | SEC FORM 4 Sold | $202284 at $0.71 | filing |
| 6 May 2022filed 6 May 2022 | Oncosec Medical | SEC FORM 4 Sold | $227274 at $0.83 | filing |
| 9 Feb 2022filed 11 Feb 2022 | Oncosec Medical | SEC FORM 4 Sold | $360409 at $0.88 | filing |
| 1 Nov 2021filed 3 Nov 2021 | Oncosec Medical | SEC FORM 4 Sold | $600343 at $1.75 | filing |
| 2 Aug 2021filed 3 Aug 2021 | Oncosec Medical | SEC FORM 4 Sold | $898412 at $2.18 | filing |
| 28 Jun 2021filed 29 Jun 2021 | Oncosec Medicaloption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 3 May 2021filed 4 May 2021 | Oncosec Medical | SEC FORM 4 Sold | $2,202453 at $4.86 | filing |
| 1 Feb 2021filed 3 Feb 2021 | Oncosec Medical | SEC FORM 4 Code A | —8,750 at $0.00 | filing |
| 24 Aug 2020filed 26 Aug 2020 | Oncosec Medicaloption or derivative | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 29 May 2020filed 3 Jun 2020 | Oncosec Medicaloption or derivative | SEC FORM 4 Code A | —54,054 at $0.00 | filing |
| 29 May 2020filed 3 Jun 2020 | Oncosec Medical | SEC FORM 4 Code A | —25,362 at $0.00 | filing |
| 29 May 2020filed 3 Jun 2020 | Oncosec Medical | SEC FORM 4 Code F | $19K8,679 at $2.23 | filing |
| 10 Apr 2018filed 12 Apr 2018 | USAU U.S. Goldoption or derivative · Diversified & Base Metal Miners | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.